| Code | 6699D | ||||||||||
| MA number | 83/0048/21-S | ||||||||||
| Product Form: | tbl mnd 2x25 mg (blis.PVC/PCTFE/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Biodemada Sp. z o. o., Poland | ||||||||||
| Therapeutic Class: | 83 - VASODILATANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PCTFE/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 12.03.2021 |
| Validity: | 12.03.2026 |
| SPC: |
SPC_MAXON 25 mg_tbl mnd_08_2022.pdf
|
| PIL: |
PIL_MAXON 25 mg_tbl mnd_08_2022.pdf
|
| Safety feature | Yes |
| Data update: | 16.03.2021 |
